APOPTOSIS INDUCTION WITH FLUDARABINE ON FRESHLY ISOLATED CHRONIC MYELOID-LEUKEMIA CELLS

被引:0
作者
ZINZANI, PL
BUZZI, M
FARABEGOLI, P
MARTINELLI, G
TOSI, P
ZUFFA, E
VISANI, G
TESTONI, N
SALVUCCI, M
BENDANDI, M
ZACCARIA, A
TURA, S
机构
关键词
CML; FLUDARABINE; APOPTOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Fludarabine (FLU) is a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Recently, some in vitro reports have showed the effective role of FLU on the activation of apoptosis. Materials and Methods. The induction of programmed cell death (apoptosis) by fludarabine (FLU), an adenine nucleoside analogue, alpha-interferon (alpha-IFN), and FLU plus alpha-IFN was evaluated in vitro against freshly isolated, chronic-phase Ph(1+) chronic myeloid leukemia (CML). Apoptosis was detected by electrophoresis gel of DNA oligonucleosomal fragments in 8 CML samples. Results. Only FLU and FLU plus alpha-IFN significantly activated apoptosis in all the samples, suggesting selective activity on CML cells. On the other hand, alpha-IFN alone did not activate programmed cell death. Conclusions. Our data show apoptotic activity for FLU on CML cells. Programmed cell death may be suppressed in cells carrying the bcr-abl transcript, and FLU might remove this resistance in the neoplastic cell cycle. This preliminary report justifies using FLU in pilot clinical trials for chronic phase Ph(1+) CML patients.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 50 条
  • [31] DHMEQ, a new NF-κB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells
    Horie, R
    Watanabe, M
    Okamura, T
    Taira, M
    Shoda, M
    Motoji, T
    Utsunomiya, A
    Watanabe, T
    Higashihara, M
    Umezawa, K
    LEUKEMIA, 2006, 20 (05) : 800 - 806
  • [32] LONG-TERM CULTURE OF CHRONIC MYELOID-LEUKEMIA (CML) BONE-MARROW CELLS
    SANTUCCI, MA
    ZACCARIA, A
    TESTONI, N
    RUSSO, D
    ZUFFA, E
    BACCARANI, M
    TURA, S
    HAEMATOLOGICA, 1991, 76 (05) : 357 - 362
  • [33] DHMEQ, a new NF-κB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells
    R Horie
    M Watanabe
    T Okamura
    M Taira
    M Shoda
    T Motoji
    A Utsunomiya
    T Watanabe
    M Higashihara
    K Umezawa
    Leukemia, 2006, 20 : 800 - 806
  • [34] Fludarabine and Gemcitabine interaction with Cytosine-arabinoside on human acute myeloid leukemia cells
    Bernabei, PA
    Santini, V
    D'Ippolito, G
    Rossi-Ferrini, P
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 217 - 221
  • [35] Induction of differentiation and apoptosis in acute myeloid leukemia (AML) cells by a novel diterpene ester
    Nouri, Kazem
    Yazdanparast, Razieh
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S364 - S364
  • [36] Overexpression of hepatocyte growth factor protects chronic myeloid leukemia cells from apoptosis induced by etoposide
    Zheng, Xiaojiao
    Hua, Shixuan
    Zhao, Hang
    Gao, Zhou
    Cen, Dong
    ONCOLOGY LETTERS, 2022, 23 (04)
  • [37] Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis
    Zovko, Ana
    Yektaei-Karin, Elham
    Salamon, Daniel
    Nilsson, Anders
    Wallvik, Jonas
    Stenke, Leif
    ONCOLOGY REPORTS, 2018, 40 (02) : 902 - 908
  • [38] Leukemia Stem Cells in Chronic Myeloid Leukemia
    Shan, Yi
    DeSouza, Ngoc
    Qiu, Qiang
    Li, Shaoguang
    LEUKEMIA STEM CELLS IN HEMATOLOGIC MALIGNANCIES, 2019, 1143 : 191 - 215
  • [39] Induction of apoptosis by Cordyceps militaris fraction in human chronic myeloid leukemia K562 cells involved with mitochondrial dysfunction
    Tian, Tian
    Song, Liyan
    Zheng, Qin
    Hu, Xianjing
    Yu, Rongmin
    PHARMACOGNOSY MAGAZINE, 2014, 10 (39) : 325 - 331
  • [40] HISTOPATHOLOGY OF CHRONIC MYELOID-LEUKEMIA IN DIAGNOSTIC BONE-MARROW BIOPSIES
    BUSCHE, G
    BUHR, T
    GEORGII, A
    PATHOLOGE, 1995, 16 (01): : 70 - 74